📣 VC round data is live. Check it out!
- Public Comps
- Nihon Kohden
Nihon Kohden Valuation Multiples
Discover Nihon Kohden's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Poly Medicure, Nolato, Vitrolife, Staar Surgical and more.
Nihon Kohden Overview
About Nihon Kohden
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
Founded
1951
HQ

Employees
6.6K
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialNihon Kohden Financials
Nihon Kohden reported last 12-month revenue of $1B and EBITDA of $158M.
In the same LTM period, Nihon Kohden generated $769M in gross profit, $158M in EBITDA, and $92M in net income.
Revenue (LTM)
Nihon Kohden P&L
In the most recent fiscal year, Nihon Kohden reported revenue of $1B and EBITDA of $162M.
Nihon Kohden is profitable as of last fiscal year, with gross margin of 52%, EBITDA margin of 11%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Nihon Kohden Stock Performance
Nihon Kohden has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Nihon Kohden's stock price is $8.79.
Nihon Kohden share price decreased by 3.3% in the last 30 days, and by 18.7% in the last year.
Nihon Kohden has an EPS (earnings per share) of $0.55.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.7% | -3.3% | -4.1% | -18.7% | $0.55 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNihon Kohden Valuation Multiples
Nihon Kohden trades at 0.9x EV/Revenue multiple, and 8.1x EV/EBITDA.
EV / Revenue (LTM)
Nihon Kohden Financial Valuation Multiples
As of June 4, 2026, Nihon Kohden has market cap of $1B and EV of $1B.
Nihon Kohden has a P/E ratio of 15.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nihon Kohden Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Nihon Kohden Margins & Growth Rates
Nihon Kohden grew revenue by 5% but EBITDA decreased by 6% in the last fiscal year.
In the most recent fiscal year, Nihon Kohden reported gross margin of 52%, EBITDA margin of 11%, and net margin of 6%.
Nihon Kohden Margins
Nihon Kohden Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Nihon Kohden Operational KPIs
Nihon Kohden's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Nihon Kohden's Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nihon Kohden's Rule of X is 9% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Nihon Kohden Competitors
Nihon Kohden competitors include Poly Medicure, Nolato, Vitrolife, Staar Surgical, Anbio Biotechnology, SKAN Group, Haier Biomedical, Savaria, VCANBIO and El.En. Group.
Most Nihon Kohden public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.8x | 6.6x | 22.9x | 27.5x | |||
| 1.4x | 1.4x | 8.5x | 8.5x | |||
| 3.9x | 3.9x | 13.4x | 13.1x | |||
| 3.9x | 4.6x | 23.7x | 67.3x | |||
| 162.7x | - | 244.0x | - | |||
| 3.5x | 3.3x | 30.5x | 25.9x | |||
| 3.6x | 3.5x | 21.3x | 21.2x | |||
| 2.4x | 2.3x | 11.6x | 11.2x | |||
This data is available for Pro users. Sign up to see all Nihon Kohden competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Nihon Kohden
Nihon Kohden has acquired 2 companies to date.
Last acquisition by Nihon Kohden was on September 12th 2024. Nihon Kohden acquired NeuroAdvanced for $15M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Nihon Kohden
| Description | NeuroAdvanced is the parent corporation of Ad-Tech Medical Instrument Corporation, a provider of precision EEG electrodes and neuroimaging accessories. Based in Nottingham, Pennsylvania, the company supplies invasive and non-invasive monitoring devices to epilepsy centers and research labs globally. Its products feature in clinical trials for over 200 hospitals in the United States. | AMP3D is a Pittsburgh-based developer of healthcare analytics platforms for predictive displays and diagnostics. Its Big Data tools forecast events like intubation, hemorrhage, and sepsis in ICUs to enable early interventions across US hospitals. |
| HQ Country | ||
| HQ City | Philadelphia, PA | Charlottesville, VA |
| Deal Date | 12 Sep 2024 | 9 Aug 2021 |
| Valuation | $15M | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Nihon Kohden acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nihon Kohden
| When was Nihon Kohden founded? | Nihon Kohden was founded in 1951. |
| Where is Nihon Kohden headquartered? | Nihon Kohden is headquartered in Japan. |
| How many employees does Nihon Kohden have? | As of today, Nihon Kohden has over 6K employees. |
| Who is the CEO of Nihon Kohden? | Nihon Kohden's CEO is Hirokazu Ogino. |
| Is Nihon Kohden publicly listed? | Yes, Nihon Kohden is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Nihon Kohden? | Nihon Kohden trades under 6849 ticker. |
| When did Nihon Kohden go public? | Nihon Kohden went public in 1961. |
| Who are competitors of Nihon Kohden? | Nihon Kohden main competitors include Poly Medicure, Nolato, Vitrolife, Staar Surgical, Anbio Biotechnology, SKAN Group, Haier Biomedical, Savaria, VCANBIO, El.En. Group. |
| What is the current market cap of Nihon Kohden? | Nihon Kohden's current market cap is $1B. |
| What is the current revenue of Nihon Kohden? | Nihon Kohden's last 12 months revenue is $1B. |
| What is the current revenue growth of Nihon Kohden? | Nihon Kohden revenue growth (NTM/LTM) is (3%). |
| What is the current EV/Revenue multiple of Nihon Kohden? | Current revenue multiple of Nihon Kohden is 0.9x. |
| What is the current EBITDA of Nihon Kohden? | Nihon Kohden's last 12 months EBITDA is $158M. |
| What is Nihon Kohden's EBITDA margin? | Nihon Kohden's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Nihon Kohden? | Current EBITDA multiple of Nihon Kohden is 8.1x. |
| What is the current FCF of Nihon Kohden? | Nihon Kohden's last 12 months FCF is $86M. |
| What is Nihon Kohden's FCF margin? | Nihon Kohden's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Nihon Kohden? | Current FCF multiple of Nihon Kohden is 14.7x. |
| How many companies Nihon Kohden has acquired to date? | As of June 2026, Nihon Kohden has acquired 2 companies. |
| What was the largest acquisition by Nihon Kohden? | $15M acquisition of NeuroAdvanced on 12th September 2024 was the largest M&A Nihon Kohden has done to date. |
| What companies Nihon Kohden acquired? | Nihon Kohden acquired NeuroAdvanced and AMP3D. |
| In how many companies Nihon Kohden has invested to date? | Nihon Kohden hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Nihon Kohden
Lists including Nihon Kohden
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
